Ramel Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 16-07-2024
- Paid Up Capital ₹ 3.20 Cr
as on 16-07-2024
- Company Age 18 Year, 3 Months
- Last Filing with ROC 31 Mar 2012
About Ramel Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2012. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 3.20 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sukanta Deb, Rameswar Podder, and Remendra Sarkar serve as directors at the Company.
- CIN/LLPIN
U85120WB2006PLC110702
- Company No.
110702
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
21 Jul 2006
- Date of AGM
19 Sep 2012
- Date of Balance Sheet
31 Mar 2012
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
North 24 Parganas, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ramel Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sukanta Deb  | Managing Director | 26-Jul-2006 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rameswar Podder | Director | 26-Jul-2006 | Current |
| Remendra Sarkar | Director | 26-Jul-2006 | Current |
Financial Performance and Corporate Structure Insights of Ramel Pharma.
Enhance accessibility to Ramel Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Ramel Pharma?
Unlock access to Ramel Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Ramel Industries Limited
Active 16 years 10 monthsSukanta Deb, Rameswar Podder and 1 more are mutual person
Tamanna It Solutions Limited
Active 18 years 25 daysSukanta Deb and Rameswar Podder are mutual person
Ramel Agrotech Private Limited
Active 15 years 28 daysSukanta Deb, Rameswar Podder and 1 more are mutual person
Ramel Sea Foods Limited
Active 13 years 8 monthsSukanta Deb, Rameswar Podder and 1 more are mutual person
Ramel Hospitality Private Limited
Active 15 years 28 daysSukanta Deb, Rameswar Podder and 1 more are mutual person
Carnation Chemicals Private Limited
Active 31 years 2 monthsSukanta Deb, Rameswar Podder and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ramel Pharma?
Unlock and access historical data on people associated with Ramel Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ramel Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ramel Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
